Search Tufts Medicine

Displaying 281 - 300 of 330
Press Releases
April 20, 2021
While families reported disruptions and added stress, many also noted positive experiences that help build resilience in a survey conducted by the American Academy of Pediatrics and partnering organizations.
Articles
June 9, 2020
In response to the COVID-19 pandemic, routine in-person healthcare visits have been temporarily put on hold in efforts to conserve personal protective equipment and to maintain social distancing. As the Centers for Medicare & Medicaid Services eased restrictions on telehealth, virtual doctor visits have become the temporary norm.
Articles
February 5, 2020
If prevention is the best medicine for good health, then early detection is a close second. Modern medicine allows us to catch many cancers and other health conditions in their earliest and most treatable stages through routine screening.
Articles
November 23, 2022
Respiratory Syncytial Virus, or RSV, is not new. Symptoms resemble the common cold and typically clear up in 1-2 weeks, so most years it blends into the range of cold-weather viruses that bring us cough and congestion.
department
Since the late 19th century, the Department of Pediatrics has been improving and redefining pediatric care, research and training.
Articles
February 14, 2021
Learn the differences between coronavirus, COVID-19 and the flu.
clinical trial
...

ARCADIA is a multicenter, biomarker-driven, randomized, double-blind, active-control, phase 3 clinical trial of apixaban versus aspirin in patients who have evidence of atrial cardiopathy and a recent stroke of unknown cause. Eleven hundred subjects will be recruited over 2.5 years at 120 sites in the NIH StrokeNet consortium. Subjects will be followed for a minimum of 1.5 years and a maximum of 4 years for the primary efficacy outcome of recurrent stroke and the primary safety outcomes of symptomatic intracranial hemorrhage and major hemorrhage other than intracranial hemorrhage.
clinical trial
...

This is a Prospective, multicenter, randomized, parallel-controlled, open-label two arm trial with an adaptive design. Eligible subjects will be randomized in a 1:1 ratio to PCI with Impella CP® (Intervention Group) versus standard of care PCI with or without IABP (Control Group). Approximately 1252 subjects will be randomized in a 1:1 ratio to PCI + Impella vs. PCI ± IABP.
Articles
January 28, 2019
Dr. Megan Evans suggests these six things before trying to become pregnant.
Patient Stories
June 12, 2019
Emily Panzone was diagnosed with vitiligo, a disease with no cure. But Tufts Medical Center provided her with the treatment she needed.
Patient Stories
January 4, 2019
Phillipe doesn’t like to sit still. An architect at a firm in Boston’s Seaport, he’s used to being on the move – at work, at home and at the gym. In early 2018, he was forced to slow down when a debilitating back injury interfered with his busy life.
Press Releases
June 13, 2019
Tufts Medical Center announced today that Ming Zhou, MD, PhD, a world-renowned urological pathologist, researcher and academic, has been named Pathologist-in-Chief